ANXA1 and inflammatory bowel disease: While mechanisms unveiling how thiazolidinediones ameliorate IBD progression are yet to be completely understood, data on AnxA1 roles on IBD suggest it might be a promising player on the actions of PPARγ ligands leading to anti-inflammatory effects.